Neutralizing Antibody Titers In Post-Covid-19 Patients And Post-Covid Pneumonia: Prognostic Value And Clinical Course

Authors

  • Bobomuratov T. A Tashkent State Medical University Tashkent, Uzbekistan.
  • Mallaev Sh. Sh
  • Fayziev N. N
  • Bobomuratov T. A

DOI:

https://doi.org/10.62480/tjms.2025.vol51.pp11-16

Keywords:

children, pneumonia, post-COVID syndrome

Abstract

Pneumonia and delayed inflammatory processes observed in the post-COVID period are associated with multiple pathophysiological mechanisms. Neutralizing antibody (NAb) titers represent a key component of the immune response to the virus, and their levels may influence disease severity, duration, and the course of post-COVID syndrome. This article analyzes the relationship between NAb titers, hematological parameters (Hb, erythrocytes, leukocytes, color index, ESR), and the clinical progression of post-COVID pneumonia in a cohort of unvaccinated patients examined after recovering from COVID-19 pneumonia.

Downloads

Published

2025-12-16

Issue

Vol. 51 (2025): TJMS

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

User Rights

Under the Creative Commons Attribution-NonCommercial 4.0 International (CC-BY-NC), the author (s) and users are free to share (copy, distribute and transmit the contribution).

Rights of Authors

Authors retain the following rights:
1. Copyright and other proprietary rights relating to the article, such as patent rights,
2. the right to use the substance of the article in future works, including lectures and books,
3. the right to reproduce the article for own purposes, provided the copies are not offered for sale,
4. the right to self-archive the article.

How to Cite

Neutralizing Antibody Titers In Post-Covid-19 Patients And Post-Covid Pneumonia: Prognostic Value And Clinical Course. (2025). Texas Journal of Medical Science, 51, 11-16. https://doi.org/10.62480/tjms.2025.vol51.pp11-16